Search Results for "Cmv Viral Load"
Original Source: Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)
This study aims to determine: a) whether those patients with 'low level' viral load results (between 200 and 3,000 copies/ml) could be monitored as opposed to starting preemptive therapy with valganciclovir, ganciclovir and/or foscarnet; b) whether those patients with 'high level' viral load results (above 3,000 copies/ml) could stop preemptive therapy earlier, thus maximising the benefits of therapy and minimising its risks.
Matching Channels
Viral pleuritis is a viral infection of the pleurae. Viral pleuritis is most commonly caused by infection with coxsackie B virus. Occasionally, echovirus causes a rare condition known as epidemic...
Matching News
Roche announces US launch of dual-target HIV-1 viral load test
Roche has launched a new FDA-approved dual-target HIV-1 viral load test to improve the ability of physicians to monitor viral load and manage the treatment of people living with human immunodeficiency...
[Personal View] Community viral load as a measure for assessment of HIV treatment as prevention
Community viral load, defined as an aggregation of individual viral loads of people infected with HIV in a specific community, has been proposed as a useful measure to monitor HIV treatment uptake and...
FDA approves Roche's new HIV viral load test
Roche announced today that a new HIV viral load test has been approved by the United States Food and Drug Administration (FDA) and will be commercially available in the US later this year.
Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy
To the Editor: Antiretroviral therapy (ART) can be used to reduce human immunodeficiency virus (HIV) transmission. For this treatment-as-prevention strategy to be effective, patients must adhere to AR...
FDA approves Roche HIV viral load test
Roche has gained FDA approval for the new HIV viral load test, the COBAS TaqMan HIV-1 Test, v2.0, and will launch the product in the US, later in 2012.
FDA clears Roche new HIV viral load test
The US Food and Drug Administration (FDA) has approved Roche's new COBAS TaqMan HIV-1 viral load test.
HIV Viral Load Test Targets Two HIV-1 Genome Regions
A new Human Immunodeficiency virus viral load test will be commercially available in the US later this year.
Roche Announces U.S. Availability Of HIV-1 Viral Load Test
SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY.PK) Wednesday said a new HIV-1 viral load test based on the company's proprietary dual-target approach is available in U.S.The new test enables labs to...
Matching PubMed Articles
Abstract Recent studies suggest that people living with HIV with lower viral load are at reduced risk for transmitting HIV to their sexual partners. As information about the association between viral...
The quantitation of HIV viral load using an assay that measures the activity of reverse transcriptase (RT) may provide an alternative strategy for the monitoring of HIV viral load within resource-limi...
BACKGROUND: Low physical activity is associated with depression, which may, in turn, negatively impact antiretroviral therapy (ART) adherence among HIV-infected individuals; however, prior studies hav...
The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Cidofovir is an antiviral agent used in the therapy of recurrent respiratory papillomatosis (RRP). In this study, we hypothesized that cidofovir is effective in decreasing the viral load of human papi...
BACKGROUND AND OBJECTIVES: To assess the use of the Epstein-Barr virus (EBV) viral load as a marker for lymphoma diagnosis in HIV-infected patients. We also aimed to identify the relationship between...
